Indaptus Therapeutics, Inc. - INDP
Detailed investor-level table based on 13F positions.
Methodology:
Market value and % of portfolio use SEC reported VALUE ($000).
For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received.
Details.
Rows: 0
| Investor | History | Status | Shares held | Market value ($000) | % of portfolio | Previous % | Rank | Change in shares | % change in shares | Source | Date reported |
|---|---|---|---|---|---|---|---|---|---|---|---|
| HRT FINANCIAL LP | History | New | 206,077 | 618 | 0.0% | — | 1 | +206,077 | New | Q2 2026 | Aug 14, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | History | Added to | 56,470 | 169 | 0.0% | 0.0% | 2 | +29,463 | 109.09% | Q2 2026 | Aug 12, 2026 |
| JANE STREET GROUP, LLC | History | New | 53,811 | 161 | 0.0% | — | 3 | +53,811 | New | Q2 2026 | Aug 14, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | History | New | 33,652 | 100 | 0.0% | — | 4 | +33,652 | New | Q2 2026 | Aug 13, 2026 |
| VANGUARD FIDUCIARY TRUST CO | History | New | 13,967 | 41 | 0.0% | — | 5 | +13,967 | New | Q2 2026 | Aug 13, 2026 |
| MILLENNIUM MANAGEMENT LLC | History | New | 11,586 | 34 | 0.0% | — | 6 | +11,586 | New | Q2 2026 | Aug 14, 2026 |
| MORGAN STANLEY | History | Added to | 8,936 | 26 | 0.0% | 0.0% | 7 | +6,239 | 231.33% | Q2 2026 | Aug 13, 2026 |
| UBS Group AG | History | New | 478 | 1 | 0.0% | — | 8 | +478 | New | Q2 2026 | Aug 13, 2026 |
| CITADEL ADVISORS LLC | History | Closed out | 0 | 0 | — | 0.0% | — | -39,018 | -100.0% | Q2 2026 | Sep 02, 2026 |
| Tower Research Capital LLC (TRC) | History | Closed out | 0 | 0 | — | 0.0% | — | -1,890 | -100.0% | Q2 2026 | Aug 11, 2026 |
| CWM, LLC | History | No change | 2 | 0 | — | — | — | 0 | 0.0% | Q1 2026 | May 14, 2026 |
| SBI Securities Co., Ltd. | History | No change | 17 | 0 | — | — | — | 0 | 0.0% | Q2 2026 | Jul 22, 2026 |